Synaptogenix Inc (SNPX)

[SF Wolf]

Dr. Alkon and his research team will be publishing the Phase 2A trial results in the next couple of weeks, prior to the Phase 2B results, as he stated in the Neurotrope presentation at the Sachs Neuroscience Biopartnering & Investment Forum (3-27-17):

Note: for some reason the presentation starts at minute 17:13

Dr. Alkon’s comments concerning the Phase 2A trial results:

Minute 29:30: “we can inject (Byrostatin) by a single IV infusion into a mammalian model and then we can measure the PKC activation and the quantity of PKC in the brain as a function of the injection.

In that way in our Phase 2A trials, which we just completed, and will be published in the next couple of weeks we can actually see the Bryostatin going up in the human patient and then you can see PKC epsilon going up to a level in the blood and then we can extrapolate based on these experiments …what is happening in the brain…across the blood brain barrier”